| 1 |
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Frank Stephen Hodi et al. · New England Journal of Medicine
Open access |
5 Jun 2010 |
15,337 |
| 2 |
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al. · The Lancet
Open access191 authors |
Dec 2012 |
14,344 |
| 3 |
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
Gregory A. Roth et al. · Journal of the American College of Cardiology
Open access679 authors |
Dec 2020 |
11,687 |
| 4 |
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry et al. · Journal of Extracellular Vesicles
Open access382 authors |
23 Nov 2018 |
11,535 |
| 5 |
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al. · Nature
Open access |
Aug 2016 |
10,439 |
| 6 |
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al. · Nature
Open access177 authors |
27 May 2020 |
10,422 |
| 7 |
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J L Murray et al. · The Lancet
Open access362 authors |
Dec 2012 |
9,055 |
| 8 |
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
Theo Vos et al. · The Lancet
Open access358 authors |
Dec 2012 |
8,461 |
| 9 |
Integrated genomic analyses of ovarian carcinoma
Debra Bell et al. · Nature
Open access255 authors |
28 Jun 2011 |
8,268 |
| 10 |
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
Julie Renee Brahmer et al. · New England Journal of Medicine
Open access |
14 Jun 2012 |
8,100 |
| 11 |
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al. · New England Journal of Medicine
Open access |
5 Jun 2011 |
7,801 |
| 12 |
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
Martin B. Leon et al. · New England Journal of Medicine
Open access |
20 Oct 2010 |
7,239 |
| 13 |
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
Theo Vos et al. · The Lancet
Open access679 authors |
7 Jun 2015 |
6,558 |
| 14 |
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith et al. · New England Journal of Medicine
Open access |
5 Jun 2011 |
6,389 |
| 15 |
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon et al. · New England Journal of Medicine
Open access |
19 Apr 2015 |
6,312 |
| 16 |
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al. · Autophagy
Open access2,467 authors |
2 Jan 2016 |
6,023 |
| 17 |
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al. · New England Journal of Medicine
Open access |
19 Apr 2015 |
5,968 |
| 18 |
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda, De‐Chen Lin, Yassen Assenov et al. · Genome Research
Open access |
19 Oct 2018 |
5,587 |
| 19 |
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond et al. · New England Journal of Medicine
Open access |
20 Oct 2005 |
5,398 |
| 20 |
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al. · Arthritis & Rheumatism
Open access |
2 May 2012 |
5,385 |
| 21 |
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
Claudio Vitali, S Bombardieri, R Jonsson et al. · Annals of the Rheumatic Diseases
Open access |
Jun 2002 |
5,366 |
| 22 |
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al. · Nature
Open access |
25 Nov 2014 |
5,353 |
| 23 |
The Somatic Genomic Landscape of Glioblastoma
Cameron Brennan et al. · Cell
Open access300 authors |
Oct 2013 |
5,261 |
| 24 |
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al. · New England Journal of Medicine
Open access |
28 Aug 2020 |
5,214 |
| 25 |
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
Martin B. Leon et al. · New England Journal of Medicine
Open access |
2 Apr 2016 |
5,107 |
| 26 |
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al. · The Lancet Oncology
Open access |
26 Oct 2014 |
5,031 |
| 27 |
Genetic studies of body mass index yield new insights for obesity biology
The LifeLines Cohort Study et al. · Nature
Open access487 authors |
10 Feb 2015 |
4,954 |
| 28 |
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al. · Nature
Open access106 authors |
31 Oct 2012 |
4,928 |
| 29 |
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al. · New England Journal of Medicine
Open access |
18 May 2014 |
4,731 |
| 30 |
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
European Alzheimer's Disease Initiative (EADI) et al. · Nature Genetics
ReviewOpen access184 authors |
27 Oct 2013 |
4,711 |
| 31 |
Prevention of Colorectal Cancer by Colonoscopic Polypectomy
Sidney J. Winawer, Ann Graham Zauber, May Nah Ho et al. · New England Journal of Medicine
Open access |
30 Dec 1993 |
4,626 |
| 32 |
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Caroline Robert et al. · New England Journal of Medicine
|
5 Jun 2011 |
4,523 |
| 33 |
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang, Pierre L. Hainaut, Gregory James Gores et al. · Nature Reviews Gastroenterology & Hepatology
ReviewOpen access |
22 Aug 2019 |
4,459 |
| 34 |
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Joshua A Welsh et al. · Journal of Extracellular Vesicles
Open access |
Feb 2024 |
4,377 |
| 35 |
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine
Open access |
18 May 2014 |
4,051 |
| 36 |
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al. · Nature
Open access1,384 authors |
5 Feb 2020 |
3,854 |
| 37 |
Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects
Margherita Maffei, Jeffrey L. Halaas, Éric Ravussin et al. · Nature Medicine
|
Nov 1995 |
3,765 |
| 38 |
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al. · The Lancet
Open access |
5 Mar 2016 |
3,762 |
| 39 |
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al. · Nature
Open access209 authors |
Aug 2010 |
3,706 |
| 40 |
Coronary Plaque Disruption
Erling Falk, Prediman Krishan Shah, Valentı́n Fuster · Circulation
|
Aug 1995 |
3,539 |
| 41 |
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Omid Hamid et al. · New England Journal of Medicine
Open access |
2 Jun 2013 |
3,425 |
| 42 |
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al. · Canadian Journal of Gastroenterology
Open access |
2005 |
3,422 |
| 43 |
Pan-cancer analysis of whole genomes
Lauri A. Aaltonen et al. · Nature
Open access1,324 authors |
5 Feb 2020 |
3,360 |
| 44 |
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd‐Price et al. · Nature
Open access |
29 May 2019 |
3,328 |
| 45 |
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al. · Nature Genetics
Open access259 authors |
6 Oct 2013 |
3,319 |
| 46 |
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg et al. · New England Journal of Medicine
Open access |
11 Jan 2017 |
3,307 |
| 47 |
Pembrolizumab for Early Triple-Negative Breast Cancer
Peter Schmid et al. · New England Journal of Medicine
Open access |
26 Feb 2020 |
3,298 |
| 48 |
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
Jonathan I. Epstein, Lars Egevad, Mahul B. Amin et al. · The American Journal of Surgical Pathology
|
22 Oct 2015 |
3,267 |
| 49 |
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
Ann Graham Zauber, Sidney J. Winawer, Michael J. O’Brien et al. · New England Journal of Medicine
Open access |
22 Feb 2012 |
3,214 |
| 50 |
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer et al. · New England Journal of Medicine
Open access |
9 Oct 1997 |
3,171 |